Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis

Neuropathology

Volumn 25, Issue 3, 2005, Pages 241-246

  Gelpi, Ellen ^a   Popovic, Mara ^b   Preusser, Matthias ^a   Budka, Herbert ^a   Hainfellner, Johannes ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Anaplasia; Differential diagnosis; GFAP; Immunohistochemistry; Pleomorphic xanthoastrocytoma

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AMELANOTIC MELANOMA; ARTICLE; ASTROCYTOMA; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT FIBROUS HISTIOCYTOMA; MITOSIS RATE; PLEOMORPHIC XANTHOASTROCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR NECROSIS; TUMOR RECURRENCE; BRAIN TUMOR; CONFOCAL MICROSCOPY; IMMUNOHISTOCHEMISTRY; MELANOMA; METABOLISM; METHODOLOGY; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 27244433430     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2005.00612.x     Document Type: Article

References (26)

1. Kleihues P, Canavee WK (eds). The WHO Classification of Tumors of the Nervous System, 1st edn. Lyon: IARC Press, 2000.
2. Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979; 44: 1839-1852.
3. Kepes JJ, Rubinstein LJ, Ansbacher L, Schreiber DJ. Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases. Acta Neuropathol (Berl) 1989; 78: 585-593.
4. Kepes JJ. Pleomorphic xanthoastrocytoma: the birth of a diagnosis and a concept. Brain Pathol 1993; 3: 269-274.
5. Chakrabarty A, Mitchell P, Bridges LR, Franks AJ. Malignant transformation in pleomorphic xanthoastrocytoma - a report of two cases. Br J Neurosurg 1999; 13: 516-519.
6. Charbel FT. Pleomorphic xanthoastrocytoma with malignant progression. Surg Neurol 1998; 50: 385-386.
7. Giannini C, Scheithauer BW, Burger PC et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999; 85: 2033-2045.
8. Paulus W, Lisle DK, Tonn JC et al. Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol (Berl) 1996; 91: 293-297.
9. Sugita Y, Shigemori M, Okamoto K, Morimatsu M, Arakawa M, Nakayama K. Clinicopathological study of pleomorphic xanthoastrocytoma: correlation between histological features and prognosis. Pathol Int 2000; 50: 703-708.
10. Hirose T, Giannini C, Scheithauer BW. Ultrastructural features of pleomorphic xanthoastrocytoma: a comparative study with glioblastoma multiforme. Ultrastruct Pathol 2001; 25: 469-478.
11. Kepes JJ. Glioblastoma multiforme masquerading as a pleomorphic xanthoastrocytoma. Childs Nerv Syst 1989; 5: 127.
12. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med 2003; 127: 1187-1191.
13. Grant JW, Gallagher PJ. Pleomorphic xanthoastrocytoma. Immunohistochemical methods for differentiation from fibrous histiocytomas with similar morphology. Am J Surg Pathol 1986; 10: 336-341.
14. Kros JM, Vecht CJ, Stefanko SZ. The pleomorphic xanthoastrocytoma and its differential diagnosis: a study of five cases. Hum Pathol 1991; 22: 1128-1135.
15. Paulus W, Peiffer J. Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors. Acta Neuropathol (Berl) 1988; 76: 245-252.
16. Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002; 26: 479-485.
17. Im SH, Chung CK, Kim SK, Cho BK, Kim MK, Chi JG. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes. J Neurooncol 2004; 66: 17-27.
18. Perry A, Giannini C, Scheithauer BW et al. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Am J Surg Pathol 1997; 21: 763-771.
19. Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 1996; 20: 80-85.
20. Vajtai I, Varga Z, Aguzzi A. Pleomorphic xanthoastrocytoma with gangliogliomatous component. Pathol Res Pract 1997; 193: 617-621.
21. Bayindir C, Balak N, Karasu A, Kasaroglu D. Anaplastic pleomorphic xanthoastrocytoma. Childs Nerv Syst 1997; 13: 50-56.
22. Bucciero A, De Caro M, De Stefano V et al. Pleomorphic xanthoastrocytoma: clinical, imaging and pathological features of four cases. Clin Neurol Neurosurg 1997; 99: 40-45.
23. Vajtai I, Yonekawa Y, Schauble B, Paulus W. Melanotic astrocytoma. Acta Neuropathol (Berl) 1996; 91: 549-553.
24. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36: 387-402.
25. Budka H. Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma. Acta Neuropathol (Berl) 1986; 72: 43-54.
26. Hainfellner JA, Voigtlander T, Strobel T et al. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol 2001; 60: 449-461.